Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Ras association and DIL domains pseudogene (ENSG00000287541) is a non-functional genomic sequence that shows significant sequence similarity to genes encoding Ras association and DIL domains, but it does **not** encode a functional protein due to inactivating mutations or loss of necessary regulatory features[1][4]. Pseudogenes like this are remnants of once-functional genes that have lost their protein-coding potential and usually do not possess biological functions ascribed to protein-coding genes. They are not considered therapeutic targets (such as receptors, enzymes, or transporters), nor are they relevant for drug-target interactions or clinical biomarker programs[1][4]. Occasionally, some pseudogenes can produce RNA transcripts that participate in gene regulation through mechanisms such as RNA interference, but no functional or disease-related role is documented for this specific pseudogene[6][7]. - The "DIL" domain and "Ras association" domain refer to protein structural features in functional Ras-association domain proteins; this pseudogene does not encode such domains in a functional protein. - The gene is best described as a non-coding, processed or unprocessed pseudogene (classification depends on its sequence origin, i.e., whether derived via duplication or retrotransposition)[1][4][5]. - It is not considered a conventional biological or pharmacological target, and there are no known drugs or clinical implications associated with this locus.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ras association and DIL domains pseudogene.